Case File
efta-efta00954544DOJ Data Set 9OtherFrom: Todd Meister
Date
Unknown
Source
DOJ Data Set 9
Reference
efta-efta00954544
Pages
2
Persons
0
Integrity
No Hash Available
Extracted Text (OCR)
Text extracted via OCR from the original document. May contain errors from the scanning process.
From: Todd Meister
To: Jeffrey Epstein <[email protected]>
Subject: Re: Manager #17 - Aindrais O'Callaghan
Date: Tue, 19 Feb 2013 14:34:52 +0000
All the quants have performance. The issue is what they can show you versus speak to because in many cases
Millenium (izzy) or a bank prop desk owned the record. The manager would leave and have to rebuild the
model. All the managers can and will talk to the prior performance. Obviously one year of performance on a
higher frequency model is statistically more relevant than a fundamental fund with few trades per month or year.
I wanted you to meet the managers to get a feel. The Millenium model fires or "trades out of managers
relatively quickly if they do not perform, so the pool of managers changes.
Sent from my iPhone
On Feb 19, 2013, at 9:01 AM, "Jeffrey Epstein" icjeeyacation((i)gmailicom> wrote:
no real performance again
On Tue, Feb 19, 2013 at 8:58 AM, Todd Meister <
> wrote:
Sent from my iPhone
Begin forwarded message:
From: Jeff Roy
Date: February 19, 2013 1:19:05 AM EST
To: Todd Meister
Subject: Manager #17 - Aindrais O'Callaghan
Reply-To: '
Attached materials for Aindrais O'Callaghan (Tijuca Capital):
Aindrais - Strategy Overview
Jeff Roy
Pridemark Management, LLC
direct: 312.788.9000
EFTA00954544
mobile: 312.719.5769
CONFIDENTIALITY NOTICE:
The information in this email and its attachments is confidential and/or privileged. This email is intended to be reviewed by only
the individual or organization named above. If you are not the intended recipient or an authorized representative of the
intended recipient, you are hereby notified that any review, dissemination or copying of this email and its attachments, if any, or
the information contained herein is prohibited. If you have received this email in error, please immediately notify the sender by
return email and delete this email from your system.
DISCLAIMERS:
This document is not intended as, and does not constitute an offer to sell or solicit any person to purchase securities. Any
mention of securities named in this document is neither a recommendation nor a solicitation. Any offer or solicitation must be
made only by means of a delivery of a private placement memorandum. No person should rely on any information in this
document, but should rely exclusively on the private placement memorandum when considering whether to invest.
These results may be based on simulated or hypothetical performance results that have certain inherent limitations. Unlike the
results shown in an actual performance record, these results do not represent actual trading. Also, because these trades have
not actually been executed, these results may have under-or over-compensated for the impact, if any, of certain market factors,
such as lack of liquidity. Simulated or hypothetical trading programs in general are also subject to the fact that they are designed
with the benefit of hindsight. No representation is being made that any account will or is likely to achieve profits or losses
similar to these being shown.
Past results are not necessarily indicative of future results.
The information contained in this communication is
confidential, may be attorney-client privileged, may
constitute inside information, and is intended only for
the use of the addressee. It is the property of
Jeffrey Epstein
Unauthorized use, disclosure or copying of this
communication or any part thereof is strictly prohibited
and may be unlawful. If you have received this
communication in error, please notify us immediately by
return e-mail or by e-mail to [email protected], and
destroy this communication and all copies thereof,
including all attachments. copyright -all rights reserved
EFTA00954545
Technical Artifacts (3)
View in Artifacts BrowserEmail addresses, URLs, phone numbers, and other technical indicators extracted from this document.
Related Documents (6)
DOJ Data Set 10OtherUnknown
EFTA01682184
186p
DOJ Data Set 10OtherUnknown
EFTA01370863
1p
Dept. of JusticeOtherUnknown
Medical Record/Clinical Encounter: DOJ-OGR-00026334
This clinical encounter document from the Bureau of Prisons details a medical evaluation of Jeffrey Epstein on July 12, 2019. It covers his medical history, current complaints, and treatment, including discussions around his triglyceride levels, sleep apnea, and back pain. The document was generated by the treating physician at the Metropolitan Correctional Center in New York.
1p
DOJ Data Set 8CorrespondenceUnknown
EFTA00014087
0p
DOJ Data Set 11OtherUnknown
EFTA02367961
1p
DOJ Data Set 10OtherUnknown
EFTA01977826
2p
Forum Discussions
This document was digitized, indexed, and cross-referenced with 1,400+ persons in the Epstein files. 100% free, ad-free, and independent.
Annotations powered by Hypothesis. Select any text on this page to annotate or highlight it.